FDA 483 - Nitto Avecia Pharma Services, Inc. - September 18, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Nitto Avecia Pharma Services, Inc. in Irvine, CA, a drug testing facility, identified two significant observations. The firm failed to adequately investigate out-of-specification results, specifically regarding repeated system suitability failures in residual solvent testing. Additionally, the firm did not follow proper change control procedures for GMP relevant changes, such as altering drug substance specifications without initiating required change controls.
ID · 4bbe0fcc-fc6d-4cd7-830e-ce3bcce6fb5a